Adherence to oral glucose lowering therapies and associations with one year HbA(1c): a retrospective cohort analysis in a large primary care database

Lignende værker

• Should Studies of Diabetes Treatment Stratification Correct for Baseline HbA1c?
  af: Jones, Angus G., et al.
  Udgivet: (2016)
• What to do with diabetes therapies when HbA1c lowering is inadequate: add, switch, or continue? A MASTERMIND study
  af: McGovern, Andrew P., et al.
  Udgivet: (2019)
• Identifying routine clinical predictors of non‐adherence to second‐line therapies in type 2 diabetes: A retrospective cohort analysis in a large primary care database
  af: Shields, Beverley M., et al.
  Udgivet: (2019)
• Sex and BMI alter the benefits and risks of sulfonylureas and thiazolidinediones in type 2 diabetes: A framework for evaluating stratification using routine clinical and individual trial data
  af: Dennis, John M, et al.
  Udgivet: (2018)
• TriMaster: randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as second-line or third-line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on metformin treatment with or without a sulfonylurea—a MASTERMIND study protocol
  af: Angwin, Catherine, et al.
  Udgivet: (2020)